Navigation Links
LA BioMed investigators, Drs. Kevin Bruhn and Noah Craft, develop novel treatment for melanoma
Date:6/25/2012

LOS ANGELES (June 25, 2012) With summer upon us, more and more people will be heading outdoors and may be putting themselves at risk for various skin conditions which can be caused by continued exposure in the sun. Kevin Bruhn, Ph.D., and Noah Craft, M.D., Ph.D. lead investigators at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) - are conducting a study that may help treat the most serious condition caused by prolonged sun exposure: skin cancer. The study will evaluate a novel immune-stimulating cream for treating melanoma, the deadliest form of skin cancer. Initial funding for this project was provided by a grant from Edison International.

Melanoma kills approximately 8,000 Americans each year, and is a growing health problem for low-income populations and ethnic minorities. Drs. Bruhn and Craft believe that melanoma can be successfully combated with treatments that harness the body's immune system. To this end, they have obtained promising results from studies of an immune-stimulating topical cream called Imiquimod. Evidence suggests that Imiquimod might be used to therapeutically treat and perhaps even cure melanomas, especially when used in conjunction with other treatments, such as surgery.

In this study, Drs. Bruhn and Craft are examining how Imiquimod combats melanoma tumors in individual patients at the genetic level. The study will enroll at least 12 untreated melanoma patients from the surrounding communities. The cream will be applied topically to localized skin areas where the tumors exist, and patients will return after two weeks of treatment with the cream to have their malignancies surgically removed. Patients' immunological responses to the treatment will then be assessed on a gene-by-gene level, using cutting-edge sequencing technologies. Drs. Bruhn and Craft are hoping that the knowledge gained from this study will help guide them and other researchers in their efforts to develop personalized immune therapy that saves people's lives.

In addition to the melanoma study, Drs. Bruhn and Craft suggest the following precautions be taken to help prevent skin cancer, which is the most common cancer.

1. It is critical to choose the right sunscreen and use it correctly. Choose at least SPF 30. But keep in mind that higher SPFs don't offer that much more protection. Don't use SPF 60 and think you can apply it half as frequently.

2. Make sure your sunscreen protects against UV-A and UV-B.

3. Don't skimp. Apply very liberally to every part of your body exposed to the sun.

4. Apply sunscreen often, at least every two hours, as it does wear off. You should apply more often if swimming or sweating.

5. Wear a hat, sunglasses, lip balm, and clothing wherever possible, especially between 10 a.m. 4 p.m., when the sun's rays are the strongest.

6. And remember, if you have any suspicious moles or spots especially if they change size, shape, or color, or have irregular edges or different colors, are painful, itchy, or oozing have them looked at by a dermatologist right away.


'/>"/>

Contact: Diana Soltesz
diana@dsmmedia.com
818-592-6747
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Source:Eurekalert

Related medicine news :

1. UMMS researcher Victor Ambros, Ph.D., named co-recipient of 2012 Janssen Award for Biomedical Research
2. UCSC physicist Alexander Sher named Pew Scholar in the Biomedical Sciences
3. Applied nanobiomedicine: Exploiting nanoparticles to hunt for hidden cancer cells
4. LA BioMeds Dr. Patricia Dickson researching treatments for neurodegenerative disorders
5. LA BioMed receives Grand Challenges Explorations grant
6. Biomedical researchers receive Hartwell Foundation awards
7. LA BioMeds Dr. John Tsuang examines effects of Ibudilast and metamphetamines
8. Elinext Leverages Latest QR Code and NFC Technologies in Mobile App Development for Retailers, Manufacturers, Advertisers, and Real Estate Companies
9. MadgeTech, Inc. Develops Temperature Recorder for Harsh Environments
10. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
11. AIUM and AUA guideline development leads to practice accreditation for urologic ultrasound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Successful recruitment ... new clinical and scientific initiatives have all marked the last 12 months at ... and CEO of the nation’s oldest cancer center, Candace S. Johnson, PhD, outlined ...
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... life? The answer may be at the tips of your toes. Foot massage, whether ... as well as pure comfort and relaxation. The American Board of Multiple Specialties ...
(Date:2/5/2016)... ... February 05, 2016 , ... US Sports Camps ... in Dover, NH to direct high-performance kids yoga training. ChildLight Yoga Studio is centrally ... one hour from Boston. , ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, ...
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure ... search for and donate to Give To Cure’s campaign that is crowdfunding clinical trials ... users make and share payments through a smart device. In 2015 alone, Venmo processed ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Dr. Justin ... announce their 2nd Annual No Cost Dental Day to individuals in need. The event ... purpose of this No Cost Dental Day is to provide dental care to community ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016  SciClone Pharmaceuticals, Inc. ... it has entered into a settlement agreement with ... fully resolving the SEC,s investigation into possible violations ... the terms of the settlement agreement, SciClone has ... including disgorgement, pre-judgment interest and a penalty.  This ...
(Date:2/4/2016)... Feb. 4, 2016 Global Immunology Market ... to drive long-term market growth Summary ... of chronic disorders that affect 5–7% of western ... of their symptoms and key patient demographics, they ... immune pathways and an inappropriate immune response. Generally, ...
(Date:2/4/2016)... DIEGO, Feb. 4, 2016  Aethlon Medical, Inc. ... affinity biofiltration devices to treat life-threatening diseases, today ... 2016 ended December 31, 2015. ... objectives set forth in our last quarterly call, ... reinforce our long-term objective to establish the Aethlon ...
Breaking Medicine Technology: